Because NfHSMI34 binds to a wider range of NfH phosphoforms than NfHSMI35, it may be that serum NfHSMI34 levels are more sensitive in detecting axonal damage in MS than serum NfHSMI35 levels. This evidence concerns the gene NEFH and myeloid sarcoma.